We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Expedeon AG Announces Commercial-Use Licence of Proprietary Technology in Diagnostic Assay

Product News   Sep 14, 2018

 
Expedeon AG Announces Commercial-Use Licence of Proprietary Technology in Diagnostic Assay

Credit: Expedeon

FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

PCR Biosystems Scales Up Operations to Ensure Availability of COVID-19 Test Reagents

Product News

PCR Biosystems are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises.

READ MORE

Clinical Validation of Portable Rapid Testing Kit for Coronavirus

Product News

MicrosensDx has announced that the test for research use in the detection of RNA from the SARS-Cov-2 virus in sputum, throat and nose swabs has now been assessed for clinical performance

READ MORE

Carterra to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Product News

Carterra® Inc. and La Jolla Institute for Immunology (LJI) have announced that they will use Carterra’s proprietary LSA™ platform to screen hundreds of antibodies in just a few days.

READ MORE

Like what you just read? You can find similar content on the communities below.

Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE